Dr. Daniel M Goodenberger MD

Chronic Obstructive Pulmonary Disease (COPD) is a progressive disease that still does not have a cure. The World Health Organization predicts that COPD will become the fourth leading cause of death worldwide by 2030. The predominant cause for COPD is tobacco smoking. Most symptoms are irreversible,...

Chronic obstructive pulmonary disease or COPD refers to a group of respiratory diseases characterized by blockage of the airways and difficulty in breathing. The most common respiratory conditions that fall into the group are chronic bronchitis and emphysema. The damage caused by COPD to the...

After years and years of studying the CFTR (cystic fibrosis transmembrane conductance regulator) gene and progress in the treatment of cystic fibrosis, researchers still have not been able to find a cure for the disease. But now, based on the findings of two independent studies, they are moving one...

The pass went way off course, and the hockey puck went flying down the street. James Cameron and another boy went sprinting after it, determined to reach it first. Hockey sticks in hand, they raced to chase down the puck. Breathing heavily, they reached it at the same time and began to struggle for...

Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...

2-year-old James Alexander Cargal is a bubbly and energetic little boy who enjoys singing, dancing, and playing with his dogs. But he is also a fighter. James was diagnosed with cystic fibrosis at just three weeks old. CF is a genetic disease that mostly affects the lungs, triggering persistent lung...